<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-PT20IUDB</identifier><date>2003</date><creator>Praprotnik, Sonja</creator><creator>Salobir, Barbara</creator><creator>Šabovič, Mišo</creator><relation>documents/doc/P/URN_NBN_SI_doc-PT20IUDB_001.htm</relation><relation>documents/doc/P/URN_NBN_SI_doc-PT20IUDB_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PT20IUDB_001.txt</relation><format format_type="issue">6</format><format format_type="volume">72</format><format format_type="type">article</format><format format_type="extent">str. 381-385</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">16589017</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PT20IUDB</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">arterijska hipertenzija</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="slv">Dušikov oksid</subject><subject language_type_id="slv">Endotelij žilni</subject><subject language_type_id="slv">Endotelini</subject><subject language_type_id="eng">Endothelins</subject><subject language_type_id="eng">Endothelium, Vascular</subject><subject language_type_id="eng">Epoprostenol</subject><subject language_type_id="slv">Hipertenzija pljučna</subject><subject language_type_id="eng">Hypertension, Pulmonary</subject><subject language_type_id="eng">Nitric Oxide</subject><subject language_type_id="eng">Pathology</subject><subject language_type_id="eng">Physiopathology</subject><subject language_type_id="slv">pljučna hipertenzija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="eng">Thromboxanes</subject><subject language_type_id="slv">Tromboksani</subject><subject language_type_id="slv">zdravljenje</subject><title>Pomen endotelijske disfunkcije za razvoj pljučne arterijske hipertenzije in nove možnosti zdravljenja</title><title>The importance of endothelial dysfunction for the development of pulmonary arterial hypertension and new therapeutic options</title></Record>